Abstract
Dopamine is an inotropic agent that has vasodilatory effects at low doses. It is a common belief that low-dose dopamine may be helpful in the prevention and treatment of acute renal failure and is being widely used in these situations. Does dopamine have a beneficial effect in acute renal failure? Numerous studies in animals and a few in humans using low-dose dopamine have been reported. In this review, the authors summarize the literature and discuss the basis of this practice, which should be considered more of a myth than an ally for this purpose.
| Original language | English |
|---|---|
| Pages (from-to) | 413-415 |
| Number of pages | 3 |
| Journal | Cardiovascular Reviews and Reports |
| Volume | 24 |
| Issue number | 8 |
| State | Published - Aug 1 2003 |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Fingerprint
Dive into the research topics of 'Renal-dose dopamine: Myth or ally in the treatment of acute renal failure?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver